Thanks for the question over IP.
Our patent portfolio is core to everything we do. It will be the foundation of any commercial deal we do. We are putting considerable time and money into making the portfolio as impregnable as possible.
We have 2 generations of patent applications, a perfectly standard situation where you upgrade your patent portfolio as you learn more about your drug – how to use it and how it works.
The 1st generation was lodged 2-3 years ago and was based on early data. The 2nd generation is far more recent and is ongoing as the clinical and preclinical data comes in. The 2nd generation patents are largely around use and clinical outcomes, which is exactly where we want to be. These 2nd generation patent applications are starting to be examined and we remain confident that the key commercial claims will be granted.
- Forums
- ASX - By Stock
- GK clarifies IP situation
Thanks for the question over IP. Our patent portfolio is core to...
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NOX (ASX) to my watchlist
(20min delay)
|
|||||
Last
11.0¢ |
Change
-0.015(12.0%) |
Mkt cap ! $32.14M |
Open | High | Low | Value | Volume |
13.0¢ | 13.0¢ | 11.0¢ | $45.44K | 375.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 629029 | 11.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
12.5¢ | 84087 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 621589 | 0.110 |
2 | 29523 | 0.105 |
5 | 149890 | 0.100 |
1 | 5 | 0.099 |
1 | 25357 | 0.098 |
Price($) | Vol. | No. |
---|---|---|
0.125 | 84087 | 1 |
0.130 | 4214 | 1 |
0.135 | 269760 | 3 |
0.140 | 443411 | 10 |
0.145 | 513000 | 3 |
Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
Featured News
NOX (ASX) Chart |